Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma

Cancer Medicine
Samuel RosnerMichael A Postow

Abstract

Both the combination of nivolumab + ipilimumab and single-agent anti-PD-1 immunotherapy have demonstrated survival benefit for patients with advanced melanoma. As the combination has a high rate of serious side effects, further analyses in randomized trials of combination versus anti-PD-1 immunotherapy are needed to understand who benefits most from the combination. Clinical laboratory values that were routinely collected in randomized studies may provide information on the relative benefit of combination immunotherapy. To prioritize which clinical laboratory factors to ultimately explore in these randomized studies, we performed a single-center, retrospective analysis of patients with advanced melanoma who received nivolumab + ipilimumab either as part of a clinical trial (n = 122) or commercial use (n = 87). Baseline routine laboratory values were correlated with overall survival (OS) and overall response rate (ORR). Kaplan-Meier estimation and Cox regression were performed. Median OS was 44.4 months, 95% CI (32.9, Not Reached). A total of 110 patients (53%) responded (CR/PR). Significant independent variables for favorable OS included the following: high relative eosinophils, high relative basophils, low absolute monocytes, ...Continue Reading

References

Mar 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ljubov SimsonChristopher R Parish
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Mar 13, 2014·Cancer Immunology, Immunotherapy : CII·Sander KeldermanChristian U Blank
Jul 19, 2014·Immunity·Roy Noy, Jeffrey W Pollard
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Apr 22, 2015·The New England Journal of Medicine·Michael A PostowF Stephen Hodi
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Nov 26, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stefan DiemJames Larkin
Dec 10, 2015·Cancer Discovery·Weiyi PengPatrick Hwu
Jan 21, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alexander MartensBenjamin Weide
Jan 24, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P F FerrucciC Martinoli
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin WeideJedd D Wolchok
Nov 20, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adil I DaudOmid Hamid
Mar 31, 2017·EBioMedicine·Michael R CassidyCharlotte Ariyan
Sep 12, 2017·The New England Journal of Medicine·Jedd D WolchokJames Larkin

❮ Previous
Next ❯

Citations

Nov 16, 2019·Journal for Immunotherapy of Cancer·J YangR D Carvajal
Jan 31, 2020·Expert Review of Anticancer Therapy·Caroline A Nebhan, Douglas B Johnson
May 19, 2020·Future Oncology·Mariona RiudavetsLaura Mezquita
Nov 28, 2018·Cancers·Daisuke NishikawaNobuhiro Hanai
Dec 13, 2018·BioMed Research International·Gang HuCheng-Yuan Liu
Jul 17, 2020·Journal of Immunology Research·Massimo RalliAntonio Greco
Aug 15, 2019·Advances in Therapy·Sanjeevani AroraYanis Boumber
Aug 17, 2019·Frontiers in Medicine·Yumi KambayashiSetsuya Aiba
Feb 13, 2020·Current Oncology Reports·Christopher G TwittyAdil I Daud
Jul 23, 2020·Nature Reviews. Cancer·Sebastien JaillonAlberto Mantovani
Oct 6, 2020·Frontiers in Immunology·Giancarlo MaroneGilda Varricchi
Sep 15, 2020·Melanoma Management·Joshua T CohenMichael P Vezeridis
Apr 3, 2020·Cancer Immunology Research·Anm Nazmul H KhanBrahm H Segal
Mar 25, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael A PostowChristopher A Barker
Jan 23, 2021·Expert Review of Clinical Immunology·Azadehsadat RazaviNima Rezaei
Jan 10, 2021·Cancers·Marcin DomagalaMary Poupot
May 29, 2020·Journal of the American Academy of Dermatology·Dulce M BarriosMario E Lacouture
Mar 30, 2021·Frontiers in Oncology·Yanna LeiMing Liu
Aug 23, 2021·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C M VilaA A Fernandez
Aug 28, 2021·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Jindrich KopeckyAneta Kyllarova
Nov 30, 2021·Archives of Dermatological Research·Kenta NakamuraRyuhei Okuyama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Pauline TétuCeleste Lebbe
The New England Journal of Medicine
Jedd D WolchokJ Larkin
The New England Journal of Medicine
Hyewon Ryu, Hyo Jin Lee
© 2022 Meta ULC. All rights reserved